当社代表取締役：菅谷 公伸のインタビュー記事がアメリカ専門雑誌「 Centennial Health Special Edition 2018 Single Issue ALZHEIMER’S – NEW HOPE FOR A CURE 」にて掲載されました。
特集記事「アルツハイマーの無い世界」にて、菅谷の開発したアルツハイマー治療薬「APC-100」がアルツハイマーモデルマウスにおける動物実験において効果を示した事が紹介されました。
https://www.synapcyte.com/synapcyte-was-featured-in-centennial-health-special-edition-2018-singe-issue-alzheimers-new-hope-for-a-cure/
SynapCyte was featured in Centennial Health Special Edition 2018 Single Issue ALZHEIMER’S – NEW HOPE FOR A CURE
SynapCyte and its lead scientific officer, Dr. Kiminobu Sugaya were featured in the article “A FUTURE WITHOUT AD”. The article highlighted Dr. Sugaya’s development of APC-100 as a potential therapy for treating AD and the promising results from his study using AD model mice.
https://www.synapcyte.com/synapcyte-was-featured-in-centennial-health-special-edition-2018-singe-issue-alzheimers-new-hope-for-a-cure/
